The impact of side-effects of antipsychotic agents on life satisfaction of schizophrenia patients: a naturalistic study

被引:87
作者
Ritsner, M
Ponizovsky, A
Endicott, J
Nechamkin, Y
Rauchverger, B
Silver, H
Modai, I
机构
[1] Shaar Menashe Mental Hlth Ctr, Inst Psychiat Studies, Hadera, Israel
[2] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel
[3] Columbia Univ, Dept Psychiat, New York, NY USA
关键词
schizophrenia; treatment adverse events; quality of life; psychosocial factors;
D O I
10.1016/S0924-977X(01)00128-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This study compared the impact of side-effects of antipsychotic treatment. clinical and psychosocial factors on the subjective quality of life (QOL) of hospitalized patients. We surveyed 161 patients meeting DSM-IV criteria for schizophrenia stabilized on conventional and atypical antipsychotic drugs using standardized measures of adverse events, psychopathology. psychosocial variables, and perceived QOL. We found that patients with adverse events reported less satisfaction with life domains of subjective feelings and general activities than asymptomatic patients. Patients treated with conventional and novel antipsychotic agents had comparable QOL ratings. Multiple regression analysis showed total variance in QOL ratings as follows: psychosocial factors, 20.9%: clinical symptoms and associated distress, 10.1%: adverse effects. 3.2%. Thus. medication side-effects influence subjective quality of life of schizophrenia inpatients significantly less than other clinical and psychosocial factors. Patient's subjective response to these events rather than their number is more predictive of QOL. (C) 2002 Published by Elsevier Science B.V./ECNP.
引用
收藏
页码:31 / 38
页数:8
相关论文
共 40 条
[1]  
Awad AG, 1997, J PSYCHIATR NEUROSCI, V22, P244
[2]  
AWAD AG, 1992, HOSP COMMUNITY PSYCH, V43, P262
[3]  
Awad AG, 1997, QUAL LIFE RES, V6, P21
[4]   Quality of life and new antipsychotics in schizophrenia - Are patients better off? [J].
Awad, AG ;
Voruganti, LNP .
INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY, 1999, 45 (04) :268-275
[5]  
BROWNE S, 1994, ACTA PSYCHIAT SCAND, P118
[6]  
Cabeza IG, 2000, SCHIZOPHR RES, V41, P349
[7]  
ENDICOTT J, 1993, PSYCHOPHARMACOL BULL, V29, P321
[8]   MULTIDIMENSIONAL ASSESSMENT OF COPING - A CRITICAL-EVALUATION [J].
ENDLER, NS ;
PARKER, JDA .
JOURNAL OF PERSONALITY AND SOCIAL PSYCHOLOGY, 1990, 58 (05) :844-854
[9]  
Essock SM, 1996, PSYCHOPHARMACOL BULL, V32, P683
[10]   Determinants of medication compliance in schizophrenia: Empirical and clinical findings [J].
Fenton, WS ;
Blyler, CR ;
Heinssen, RK .
SCHIZOPHRENIA BULLETIN, 1997, 23 (04) :637-651